HDACs and sirtuins: Targets for new pharmacological interventions in human diseases

Pharmacological Research

Volumn 62, Issue 1, 2010, Pages 1-2

  Puri, Pier Lorenzo ^a,b   Sartorelli, Vittorio ^b,c  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b BURNHAM INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN; SIRTUIN 1;

CARDIOVASCULAR DISEASE; CELL DEATH; CELL DIFFERENTIATION; CELL ENERGY; CELL PROLIFERATION; CELL SURVIVAL; EDITORIAL; ENERGY METABOLISM; ENZYME ACTIVITY; HOMEOSTASIS; INFLAMMATION; METABOLIC REGULATION; NEUROMUSCULAR DISEASE; OXIDATION REDUCTION STATE; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL;

ANIMALS; DISEASE; DISEASE MODELS, ANIMAL; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; SIRTUINS;

EID: 77952804316     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.04.003     Document Type: Editorial

References (0)